Zaleplon
NDC Package 67877-211-10

11-digit billing NDC: 67877021110

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Zaleplon is indicated for the short-term treatment of insomnia. Marketed by Ascend Laboratories, Llc, this product is identified by NDC 67877-211 and is authorized under FDA application ANDA078989.

Identification & Billing

NDC Package Code
67877-211-10
Package Description
1000 CAPSULE in 1 BOTTLE
Product Code
11-Digit Billing Format
67877021110
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Zaleplon
Dosage Form
-
Usage Information
Zaleplon is indicated for the short-term treatment of insomnia. Zaleplon has been shown to decrease the time to sleep onset for up to 30 days in controlled clinical studies (see Clinical TrialsĀ under CLINICAL PHARMACOLOGY). It has not been shown to increase total sleep time or decrease the number of awakenings.The clinical trials performed in support of efficacy ranged from a single night to 5 weeks in duration. The final formal assessments of sleep latency were performed at the end of treatment.

Regulatory & Marketing

Labeler Name
Ascend Laboratories, Llc
FDA Application #
ANDA078989
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-15-2010
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (67877-211). Click a package code to view its specific billing and regulatory data.

100 CAPSULE in 1 BOTTLE
500 CAPSULE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 67877-211-10 identifies a specific commercial package of 1000 capsule in 1 bottle of Zaleplon, labeled by Ascend Laboratories, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Ascend Laboratories, Llc on December 15, 2010. The current certification is valid through December 31, 2017.

How is this Ascend Laboratories, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 67877021110. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
67877-211-10
11-Digit CMS (5-4-2)
67877-0211-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.